Dublin, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The "Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Equine Encephalitis" report has been added to ResearchAndMarkets.com's offering.
The Equine Encephalitis Infection pipeline guide presents complete overview of drugs currently being developed for Equine Encephalitis Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Equine Encephalitis Infection pipeline candidate. Research and Development progress along with latest news related to each of the Equine Encephalitis Infection pipeline candidates is included.
Major companies participating in therapeutic development of Equine Encephalitis Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.
Amid strong interest for cure of Equine Encephalitis Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Equine Encephalitis Infection clinical and pre-clinical products.
The report assists in identifying potential upcoming companies and drugs in Equine Encephalitis Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
Scope of Equine Encephalitis Infection pipeline report includes:
- Panorama of Equine Encephalitis Infection pipeline markets including statistics on therapeutic drugs and companies involved
- Equine Encephalitis Infection Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered
- Equine Encephalitis Infection pipeline candidates across various Mechanism of Actions' are also presented in the study
- Overview of companies participating in Equine Encephalitis Infection pipeline with short introduction to their businesses and pipeline projects
- For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.
- Research and Development progress and trial details, results wherever available, are also included in the pipeline study
- The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Equine Encephalitis Infection pipeline therapeutics
Reasons to Buy:
- Get clear understanding of the entire Equine Encephalitis Infection pipeline, with details on active projects
- Get in detail information of each product with updated information on each project along with key milestones
- Know the list of companies participating in global Equine Encephalitis Infection pipeline along with progress of each of the company's products and information on associations/collaborations/licensing data
- Get trial information for each pipeline product under development
- Understand the pipeline structure in terms of mechanism of Action, phase and company
Key Topics Covered:
I. Key Findings
1. Companies Investing in Equine Encephalitis Infection Pipeline include-
Number of Companies with Equine Encephalitis Infection projects in pre-clinical Development-
Number of Companies with Equine Encephalitis Infection projects in Clinical Development-
Equine Encephalitis Infection Pipeline Companies based in Americas
Equine Encephalitis Infection Pipeline Companies based in Europe
Equine Encephalitis Infection Pipeline Companies based in Asia Pacific
Equine Encephalitis Infection Pipeline Companies based in Rest of the World
2. Pipeline Candidates include-
Equine Encephalitis Infection Pipeline Agents in pre- clinical/ Discovery stage of Development
Equine Encephalitis Infection Pipeline Agents in Clinical Development stage
Equine Encephalitis Infection Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs-
Small molecules among the Equine Encephalitis Infection Pipeline agents
II. Insights into Equine Encephalitis Infection Pipeline -
1. Disease Overview
Introduction to Equine Encephalitis Infection
Symptoms and Causes of Equine Encephalitis Infection
Treatment or Prevention Options for Equine Encephalitis Infection
Other Details
2. Phase wise Pipeline Compounds
Equine Encephalitis Infection Pipeline- Pre- Clinical/ Discovery stage Drugs
Equine Encephalitis Infection Pipeline- Phase 1 stage Drugs
Equine Encephalitis Infection Pipeline- Phase 2 stage Drugs
Equine Encephalitis Infection Pipeline- Phase 3 stage Drugs
Equine Encephalitis Infection Pipeline- Pre-Registration stage Drugs
3. Company wise Equine Encephalitis Infection Pipeline Compounds
4. Equine Encephalitis Infection Pipeline by Mechanism of Action
III. Equine Encephalitis Infection Pipeline Compound Details
- WEEV vaccine
- Eastern Equine Encephalitis vaccine 2
- equine encephalitis vaccine
- monoclonal antibody (mAb) therapeutics for Equine Encephalitis
- Monoclonal Antibody for Venezuelan Equine Encephalitis
- VEEV vaccine
- VesiculoVax Prophylactic Vaccines
Drug Details
1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co-Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details
IV. Equine Encephalitis Infection Pipeline Company Briefs
- Akshaya Bio Inc.
- Bavarian Nordic
- EpiVax, Inc.
- Integrated BioTherapeutics, Inc.
- Mapp Biopharmaceutical, Inc.
- Medigen, Inc.
- Profectus BioSciences Inc
V. Latest News and Developments in Global Equine Encephalitis Infection Pipeline Market
VI. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/9rd35g/equine?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.